TY - JOUR
T1 - Designing a theory-based intervention to improve the guideline-concordant use of imaging to stage incident prostate cancer
AU - Ciprut, Shannon
AU - Sedlander, Erica
AU - Watts, Kara L.
AU - Matulewicz, Richard S.
AU - Stange, Kurt C.
AU - Sherman, Scott E.
AU - Makarov, Danil V.
N1 - Funding Information:
Funding: Funding for this study was provided by the United States Department of Veterans Affairs, Veterans Health Administration, Health Services Research, and Development Service. Dr. Makarov is a VA HSR&D Career Development Awardee at the Manhattan VHA (grant numbers CDA11-257 & CDP 11-254). The Edward Blank and Sharon Cosloy-Blank Family Foundation, The Gertrude and Louis Feil Family Charitable Lead Trust, the New York State Prostate Cancer Research Grant, and The NCI Cancer Center Support Grant P30CA016087 also contributed to the funding of this study.
Publisher Copyright:
© 2018
PY - 2018/5
Y1 - 2018/5
N2 - Among US men, most new prostate cancer cases are clinically localized and do not require imaging as part of staging workup according to guidelines. Two leading specialty societies promote stewardship of health resources by encouraging guideline-concordant care, thereby limiting inappropriate and obsolete imaging. However, imaging to stage low-risk prostate cancer remains high, as almost half of men with localized prostate cancer undergo wasteful imaging following diagnosis. We employed a theory-based approach, based on current evidence and data on existing practice patterns revealing that providers are the drivers to imaging decisions, to design an intervention to improve guideline -concordant prostate cancer staging imaging across populations. We conceptualized preliminary results using the theoretical domains framework and the behavior change wheel, frameworks used concurrently to investigate physicians′ behaviors and intervention design in various clinical settings. Through these 2 frameworks, we designed a theory-based, physician-focused intervention to efficiently encourage guideline-concordant prostate cancer imaging, prostate cancer imaging stewardship (PCIS). Prostate cancer imaging stewardship consists of interventions (clinical order check, academic detailing, and audit and feedback) implemented at the individual, facility, and system level to enact provider behavior change by enabling facilitators and appealing to physician motivation.
AB - Among US men, most new prostate cancer cases are clinically localized and do not require imaging as part of staging workup according to guidelines. Two leading specialty societies promote stewardship of health resources by encouraging guideline-concordant care, thereby limiting inappropriate and obsolete imaging. However, imaging to stage low-risk prostate cancer remains high, as almost half of men with localized prostate cancer undergo wasteful imaging following diagnosis. We employed a theory-based approach, based on current evidence and data on existing practice patterns revealing that providers are the drivers to imaging decisions, to design an intervention to improve guideline -concordant prostate cancer staging imaging across populations. We conceptualized preliminary results using the theoretical domains framework and the behavior change wheel, frameworks used concurrently to investigate physicians′ behaviors and intervention design in various clinical settings. Through these 2 frameworks, we designed a theory-based, physician-focused intervention to efficiently encourage guideline-concordant prostate cancer imaging, prostate cancer imaging stewardship (PCIS). Prostate cancer imaging stewardship consists of interventions (clinical order check, academic detailing, and audit and feedback) implemented at the individual, facility, and system level to enact provider behavior change by enabling facilitators and appealing to physician motivation.
KW - Behavior Change Wheel
KW - Theoretical Domains Framework
KW - guidelines
KW - imaging
KW - implementation
KW - prostate cancer
UR - http://www.scopus.com/inward/record.url?scp=85041567116&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85041567116&partnerID=8YFLogxK
U2 - 10.1016/j.urolonc.2017.12.019
DO - 10.1016/j.urolonc.2017.12.019
M3 - Review article
C2 - 29398250
AN - SCOPUS:85041567116
SN - 1078-1439
VL - 36
SP - 246
EP - 251
JO - Urologic Oncology: Seminars and Original Investigations
JF - Urologic Oncology: Seminars and Original Investigations
IS - 5
ER -